Nephron Pharmaceuticals Corporation
UEI: S7MNQGDTFDN9
• CAGE: 0TU69
Overview
Awardee Type
Parent
(1 child)
Company Description
Nephron is a world leader in generic respiratory medication manufacturing, and offers drug compounding for 503B outsourcing through its sterile, cGMP facility.
Name
Nephron Pharmaceuticals Corporation
Website
Headquarters
West Columbia, SC
United States
United States
Most Recent Award
Jan. 30, 2025
Calculating
Federal contract recipient
NEPHRON PHARMACEUTICALS CORPORATION
(UEI S7MNQGDTFDN9, CAGE 0TU69)
is headquartered in West Columbia SC.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in August 1992 and
federally registered in
March 2002.
Federal Award Analysis
Nephron Pharmaceuticals Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NEPHRON PHARMACEUTICALS CORPORATION
Division Name
NATIONAL ACCOUNTS
UEI
S7MNQGDTFDN9
CAGE Code
0TU69
Primary NAICS
SBA Certifications
None
Self Certifications
Woman Owned Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 12, 1992
Initial Registration
March 4, 2002
Last Registration
Feb. 20, 2025
Registration Activation
Nov. 20, 2024
Registration Expiration
Nov. 14, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Subchapter S Corporation
Manufacturer of Goods
Subchapter S Corporation
State of Incorporation
FL
Country of Incorporation
USA
Employees
751-1000
Disaster Registry
Nationwide
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Nephron Pharmaceuticals Corporation
GSA Schedules and Price Lists
- Nephron Pharmaceuticals Corporation
- PoP: 2/28/18 - 2/28/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)